Sharda Cropchem Limited — PPTs, 13-05-2026: Investor Presentation

Sharda Cropchem delivered a robust performance for Q4 and FY26.

1. **Business Performance:** Q4 FY26 revenue surged 13% to 2,065 Cr, with full-year revenue growing 22% to 5,268 Cr. Agrochemicals, the dominant segment, drove strong volume growth across Europe and Latin America.

2. **Growth Drivers & Strategy:** The company maintains an asset-light model, strategically focusing on building a direct 'factory-to-farmer' sales force. Key priorities include geographical expansion, continuous investment in new product registrations, and boosting operational efficiencies.

3. **Recent Developments:** FY26 saw Sharda Cropchem achieve its highest-ever annual Profit After Tax. They also invested 505 Cr in capex and significantly expanded their global product registrations, securing 3,011 and filing another 1,004 applications.

4. **Key Financial Metrics:** For FY26, PAT jumped 124% to 681 Cr, and EBITDA rose 69% to 1,040 Cr. Gross Margins improved 600 basis points to 35.9%. RoCE stood at 30.4% and RoE at 24.2%, with working capital days reducing by 20.

5. **Management Outlook:** Management expects gross margins to remain stable in FY27, leveraging global demand for crop protection driven by a growing population and shrinking arable land. They aim to capitalize on their strong global presence and product portfolio.